SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-003919
Filing Date
2024-11-14
Accepted
2024-11-14 19:17:24
Documents
2
Group Members
JEFF EASTONLIND GLOBAL PARTNERS II LLC

Document Format Files

Seq Description Document Type Size
1 sch13g.htm SC 13G/A 66053
2 JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS exhibit99-1.htm EX-99.1 7567
  Complete submission text file 0000929638-24-003919.txt   75408
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88748 | Film No.: 241465178
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022
Business Address 444 MADISON AVENUE 41ST FLOOR NEW YORK NY 10022 646-701-7428
Lind Global Fund II LP (Filed by) CIK: 0001871665 (see all company filings)

IRS No.: 863914253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A